Rigel Pharmaceutical Inc. buy StockNews.com
Start price
12.03.24
/
50%
€1.37
Target price
12.03.25
-
Performance (%)
-26.57%
Price
26.04.24
€1.02
Summary
This prediction is currently active. The price of Rigel Pharmaceutical Inc. has decreased since the start of the prediction. Compared to the start price this results in a performance of -26.57%. This prediction currently runs until 12.03.25. The prediction end date can be changed by StockNews_com at any time. StockNews_com has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Rigel Pharmaceutical Inc. | -4.303% | -4.303% |
| iShares Core DAX® | 2.594% | -1.861% |
| iShares Nasdaq 100 | 3.553% | -2.064% |
| iShares Nikkei 225® | 0.687% | -8.704% |
| iShares S&P 500 | 2.209% | -1.988% |
Comments by StockNews_com for this prediction
In the thread Rigel Pharmaceutical Inc. diskutieren
Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Ratings data for RIGL provided by MarketBeat
Stopped prediction by StockNews_com for Rigel Pharmaceutical Inc.
Rigel Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€0.67
27.10.23
27.10.23
-
27.10.24
27.10.24
45.91%
26.04.24
26.04.24
Rigel Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€1.00
23.09.23
23.09.23
-
23.09.24
23.09.24
3.16%
26.04.24
26.04.24